Teva and Mylan get green light to launch Novartis generics

08-01-2015

Teva and Mylan get green light to launch Novartis generics

LeventeGyori / Shutterstock.com

Pharmaceutical companies Teva and Mylan have each been granted permission to market a generic version of Novartis’s blood pressure treatment Diovan (valsartan) in the US.


Teva, Mylan, Novartis, Diovan, ANDA

LSIPR